GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Mydecine Innovations Group Inc (OTCPK:MYCOF) » Definitions » Cyclically Adjusted FCF per Share

MYCOF (Mydecine Innovations Group) Cyclically Adjusted FCF per Share : $-17.14 (As of Sep. 2024)


View and export this data going back to 2015. Start your Free Trial

What is Mydecine Innovations Group Cyclically Adjusted FCF per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

Mydecine Innovations Group's adjusted free cash flow per share for the three months ended in Sep. 2024 was $0.001. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is $-17.14 for the trailing ten years ended in Sep. 2024.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

As of today (2025-05-18), Mydecine Innovations Group's current stock price is $0.0034. Mydecine Innovations Group's Cyclically Adjusted FCF per Share for the quarter that ended in Sep. 2024 was $-17.14. Mydecine Innovations Group's Cyclically Adjusted Price-to-FCF of today is .


Mydecine Innovations Group Cyclically Adjusted FCF per Share Historical Data

The historical data trend for Mydecine Innovations Group's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Mydecine Innovations Group Cyclically Adjusted FCF per Share Chart

Mydecine Innovations Group Annual Data
Trend Aug14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -23.32

Mydecine Innovations Group Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -20.73 -23.32 - - -17.14

Competitive Comparison of Mydecine Innovations Group's Cyclically Adjusted FCF per Share

For the Drug Manufacturers - Specialty & Generic subindustry, Mydecine Innovations Group's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Mydecine Innovations Group's Cyclically Adjusted Price-to-FCF Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Mydecine Innovations Group's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Mydecine Innovations Group's Cyclically Adjusted Price-to-FCF falls into.


;
;

Mydecine Innovations Group Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Mydecine Innovations Group's adjusted Free Cash Flow per Share data for the three months ended in Sep. 2024 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Sep. 2024 (Change)*Current CPI (Sep. 2024)
=0.001/127.2847*127.2847
=0.001

Current CPI (Sep. 2024) = 127.2847.

Mydecine Innovations Group Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201412 0.000 98.367 0.000
201503 -26.714 99.789 -34.075
201506 -13.160 100.500 -16.667
201509 -4.333 100.421 -5.492
201512 -1.000 99.947 -1.274
201603 -2.407 101.054 -3.032
201606 -3.321 102.002 -4.144
201609 -0.833 101.765 -1.042
201612 -19.596 101.449 -24.587
201703 -17.878 102.634 -22.172
201706 -15.696 103.029 -19.391
201709 -2.310 103.345 -2.845
201712 -29.038 103.345 -35.765
201803 -8.483 105.004 -10.283
201806 -19.637 105.557 -23.679
201809 -4.684 105.636 -5.644
201812 0.270 105.399 0.326
201903 -3.755 106.979 -4.468
201906 -0.494 107.690 -0.584
201909 -0.863 107.611 -1.021
201912 -0.181 107.769 -0.214
202003 -0.018 107.927 -0.021
202006 -1.094 108.401 -1.285
202009 -0.410 108.164 -0.482
202012 -0.670 108.559 -0.786
202103 -1.742 110.298 -2.010
202106 -0.802 111.720 -0.914
202109 -0.983 112.905 -1.108
202112 -0.746 113.774 -0.835
202203 -0.272 117.646 -0.294
202206 -0.443 120.806 -0.467
202209 -0.118 120.648 -0.124
202212 -0.073 120.964 -0.077
202303 -0.118 122.702 -0.122
202306 -0.025 124.203 -0.026
202309 -0.001 125.230 -0.001
202312 -0.005 125.072 -0.005
202403 0.000 126.258 0.000
202406 0.000 127.522 0.000
202409 0.001 127.285 0.001

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.


Mydecine Innovations Group  (OTCPK:MYCOF) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


Mydecine Innovations Group Cyclically Adjusted FCF per Share Related Terms

Thank you for viewing the detailed overview of Mydecine Innovations Group's Cyclically Adjusted FCF per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Mydecine Innovations Group Business Description

Traded in Other Exchanges
Address
1890 – 1075 West Georgia Street, Suite 810, Vancouver, BC, CAN, V6E 3C9
Mydecine Innovations Group Inc is a biopharma and life sciences company engaged in the research, drug development, and clinical trials of psilocybin products.

Mydecine Innovations Group Headlines